Details for New Drug Application (NDA): 011559
✉ Email this page to a colleague
The generic ingredient in BREVITAL SODIUM is methohexital sodium. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methohexital sodium profile page.
Summary for 011559
Tradename: | BREVITAL SODIUM |
Applicant: | Endo Operations |
Ingredient: | methohexital sodium |
Patents: | 0 |
Suppliers and Packaging for NDA: 011559
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BREVITAL SODIUM | methohexital sodium | INJECTABLE;INJECTION | 011559 | NDA | Endo USA, Inc. | 42023-105 | 42023-105-01 | 1 VIAL in 1 CARTON (42023-105-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 500MG/VIAL | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AP | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 2.5GM/VIAL | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 5GM/VIAL | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription